Bioharvest Sciences (BHST) Cash & Current Investments (2023 - 2025)

Bioharvest Sciences' Cash & Current Investments history runs 3 years deep, the most recent figure standing at $23.0 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 863.39% year-over-year to $23.0 million; the TTM figure through Dec 2025 stood at $23.0 million (up 863.39% YoY), while the FY2025 annual figure was $23.0 million, up 329.97% from the prior year.
• Cash & Current Investments was $23.0 million for Q4 2025 at Bioharvest Sciences, up from $2.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $23.0 million in Q4 2025 to a low of $1.7 million in Q2 2023.
• Historically, Cash & Current Investments has averaged $5.2 million across 3 years, with a median of $2.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 55.37% in 2024, then soared 863.39% in 2025.
• A 3-year view of Cash & Current Investments shows it stood at $5.4 million in 2023, then plunged by 55.37% to $2.4 million in 2024, then jumped by 863.39% to $23.0 million in 2025.
• The last three Cash & Current Investments figures came in at $23.0 million (Q4 2025), $2.4 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.